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Since the outbreak of coronavirus disease 2019 (COVID-19) in China in December 2019
and its rapid worldwide spread, the real-time reverse transcription–polymerase chain
reaction (rRT–PCR) test has become the gold standard for the etiological diagnosis of
COVID-19 infection [1]. However, for countries with limited health resources, rRT–PCR
test is relatively expensive and requires specialized laboratories and highly trained
personnel [2].
Recent studies have shown that some routine blood test markers might help in the
diagnosis of COVID-19 infection in suspected patients with a very high predictive value
(>95%) [3]. This editorial aims to assess the role of blood markers in diagnosing COVID-
19 infection as an alternative for rRT–PCR in countries with limited health resources by
performing online search in electronic databases such as Medline, Scopus, and Web
of Science, using keywords such as “blood markers’ role in diagnosis of COVID 19.”
Additionally, the references of identified documents were cross-checked for detecting
additional studies. Overall, 203 articles were found using the aforementioned search
criteria, of which 200 were excluded after scrutinization by the authors. Only three
studies were finally selected and used in the present editorial based on the comparison
of the final diagnosis reached by rRT–PCR and the high predictive value of blood
markers. Another reason for excluding most studies was that they focused on the
disease outcome rather than the diagnostic value.
Santotoribio et al. (2019) evaluated the role of six routine blood tests (blood lym-
phocyte, eosinophil count, ferritin serum level, lactate dehydrogenase (LDH), C-reactive
protein (CRP), and D-dimer) in diagnosing cases of suspected COVID-19 [4. The study
showed that 91% of patients infected with COVID-19 met one or more of these biomarker
criteria. Thus, it is possible to rule out coronavirus infection with a high degree of
probability in patients who meet none of these criteria. They concluded that these
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markers could very well be used as a tool for diagnosing and screening suspected
COVID-19 in adult patients at hospital admission.
Another study by Ferrari et al. compared the routine blood analysis of the plasma
levels of white blood cells (WBCs), platelets, CRP, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), alkaline phosphatase
(ALP), and LDH of 207 patients who had tested positive for COVID-19 using the rRT–PCR
test [5].
The results showed statistically significant differences in the plasma levels of WBC,
CRP, AST, ALT, and LDH between those who were positive and those who were negative
at the genetic testing. Using rRT–PCR as the gold standard, almost 70% of the patients
could be classified as COVID-19-positive or -negative on the basis of their hematological
parameters.
The last study was conducted in Sudan under the supervision of the authors of this
editorial [6]. The study included 56 patients who had all tested positive for COVID-
19 using rRT–PCR. For all patients, the complete blood count (CBC), CRP, erythrocyte
sedimentation rate (ESR), total protein, albumin, total and direct bilirubin, AST, ALT, ALP,
urea, creatinine, and electrolytes were measured upon admission. In this study, intense
statistical analyses were done using the SPSS program. With a significance level of p
≤ 0.05 and confidence limits (CLs) of 95%, group comparison was tested using Mann–
Whitney test for quantitative variables while qualitative variables were tested using Chi-
square (fisher exact) test. The receiver operating characteristic/area under the curve
(ROC/AUC) was used to obtain the true positive, and false positive predictive values
were calculated using the best cutoff values.
The ROC/AUC ensured the appellant result of lymphocytes (%) as a predictor with
92% AUC, 90% neutrophils, 95.8% ESR, 89% CRP, and 86.8% WBCs. About 98% of
the suspected individuals diagnosed with COVID-19 using ROC showed a cutoff of
<=21.8 for lymphocytes (%), >=67.7 for neutrophils, >=37.5 for ESR, >=6.2 for CRP,
and >=7.15 for WBCs. The applicable value of these studies based on the fact that
hospitals in developing countries, including the ones with limited health resource, have
the facilities of automated analyzers that can test for these inexpensive highly sensitive
and specific bloodmarkers in<60min. If physicians combine the bloodmarkers with the
medical history and imaging tests, they can very well diagnose and/or screen patients
suspected of COVID-19. In addition to that, using blood markers in diagnosis may be
crucial in detecting a new genetic variant of Coronavirus, that is, the Indian strain in
which molecular testing encounters a high percentage of false-positive/negative cases.
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